Literature DB >> 10029343

Effect of a pulsating anti-gravity suit on peak exercise performance in individual with spinal cord injuries.

S Houtman1, J J Thielen, R A Binkhorst, M T Hopman.   

Abstract

The aim of this study was to examine effects of a pulsating pressure anti-gravity suit on the peak values of oxygen uptake (VO2) and power during maximal arm exercise in spinal-cord-injured (SCI) individuals. Five well-trained SCI men (with lesions at levels between T6 and L1) and seven well-trained able-bodied men (ABC) performed two incremental (10 W x min(-1)) arm-cranking tests. During one test the pressure in the anti-G suit pulsated between 4.7 kPa (35 mmHg) and 9.3 kPa (70 mmHg) every 2 s (PPG+), during the other test (PPG-) all the subjects wore the anti-G suit in a deflated state. Tests were performed in a counter-balanced order. Peak VO2 in SCI was 1 ml x kg(-1) x min(-1) lower during PPG+ compared to PPG- (P = 0.05). Peak power and peak heart rate were not significantly different during PPG+ compared to PPG-. These results would suggest that no increase in work capacity can be obtained with a pulsating pressure anti-gravity suit in either SCI or ABC.

Entities:  

Mesh:

Year:  1999        PMID: 10029343     DOI: 10.1007/s004210050496

Source DB:  PubMed          Journal:  Eur J Appl Physiol Occup Physiol        ISSN: 0301-5548


  3 in total

1.  Effect of lower limb compression on blood flow and performance in elite wheelchair rugby athletes.

Authors:  Joanna Vaile; Brad Stefanovic; Christopher D Askew
Journal:  J Spinal Cord Med       Date:  2016-02-11       Impact factor: 1.985

Review 2.  Exercise recommendations for individuals with spinal cord injury.

Authors:  Patrick L Jacobs; Mark S Nash
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

3.  Effects of compression stockings on sympathetic activity and heart rate variability in individuals with spinal cord injury.

Authors:  Diana Rimaud; Paul Calmels; Vincent Pichot; Francois Bethoux; Frederic Roche
Journal:  J Spinal Cord Med       Date:  2012-02-04       Impact factor: 1.985

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.